Fluconazole therapy for treatment of invasive candidiasis in Intensive Care patients. Is it still valid from a pharmacological point of view?

Fluconazole therapy for treatment of invasive candidiasis in Intensive Care patients. Is it still valid from a pharmacological point of view?

Fluconazole – antimycotic belonging to the first generation azoles – is widely used as treatment for invasive candidiasis and candidemia in numerous clinical settings as Neonatal Intensive Care Unit (NICU) and adult Intensive Care Unit (ICU), as well as oncology, onco-hematology and solid organ tran...

Full description

Bibliographic Details
Main Authors: Mario Musu, Maurizio Evangelista, Paolo Mura, Andrea Cossu, Massimiliano Carta, Gian Nicola Aru, Gabriele Finco
Format: Article
Language:English
Published: Hygeia Press di Corridori Marinella 2014-03-01
Series:Journal of Pediatric and Neonatal Individualized Medicine
Subjects:
fluconazole
invasive candidiasis
icu
apache ii score
sensitivity
resistance
Online Access:https://www.jpnim.com/index.php/jpnim/article/view/133

Internet

https://www.jpnim.com/index.php/jpnim/article/view/133

Similar Items